| Nummer | Kunde | Datum | Status | Total | Aktionen |
|---|---|---|---|---|---|
| 2026-16434 | Bilfinger Life Science GmbH | 09.11.2026 | draft | EUR 90'000.00 | |
| 2026-16433 | LONZA AG | 09.11.2026 | draft | CHF 4'264.55 | |
| 2026-16432 | LONZA AG | 09.11.2026 | draft | CHF 4'264.55 | |
| 2026-16431 | Novo Nordisk A/S | 09.11.2026 | draft | CHF 208'408.17 | |
| 2026-16430 | LONZA AG | 09.11.2026 | draft | CHF 1'308.01 | |
| 2026-16429 | Novo Nordisk A/S | 09.11.2026 | draft | CHF 208'408.17 | |
| 2026-16428 | LONZA AG | 09.11.2026 | draft | CHF 53'779.75 | |
| 2026-16427 | LONZA AG | 09.11.2026 | draft | CHF 29'716.69 |